Particle bounce in a personal cascade impactor: a field evaluation

Inhalation drug delivery devices: technology update

The pulmonary route of administration has proven to be effective in local and systemic delivery of miscellaneous drugs and biopharmaceuticals to treat pulmonary and non-pulmonary diseases. A successful pulmonary administration requires a harmonic interaction between the drug formulation, the inhaler device, and the patient. However, the biggest single problem that accounts for the lack of desired effect or adverse outcomes is the incorrect use of the device due to lack of training in how to use the device or how to coordinate actuation and aerosol inhalation. This review summarizes the structural and mechanical features of aerosol delivery devices with respect to mechanisms of aerosol generation, their use with different formulations, and their advantages and limitations. A technological update of the current state-of-the-art designs proposed to overcome current challenges of existing devices is also provided.

Reducing bounce effects in the Andersen cascade impactor

The collection efficiency of the Andersen cascade impactor (ACI) can be affected by particle bounce, overload and re-entrainment (or blow-off), collectively referred to as bounce effects. Reduction of bounce effects in the ACI operated at 60 LPM was investigated for placebo large porous particles. Aerodynamic particle size distributions (aPSDs) obtained with the ACI and multi-stage liquid impinger (MSLI) were compared by observation of modes and statistical comparisons of the mass median aerodynamic diameter (MMAD) and geometric standard deviation (sigmag). Particle bounce effects were prevalent in the ACI with uncoated plates, i.e., bi-modal distribution with statistically significant differences in MMAD and sigmag (P<0.05). Coating the impaction plates with a thin layer of vacuum grease and decreasing the ACI stage jet velocities reduced, but did not minimize bounce effects. Bounce effects were minimized using 20-microm pore glass fiber filters saturated in water placed on inverted impaction plates, with good agreement obtained between the ACI and MSLI aPSDs, i.e., mono-modal with no statistically significant differences in MMAD and sigmag (P>0.05). Selection of the impaction substrate material and solvent must be evaluated with the drug product and analytical methods to minimize bounce effects and obtain an accurate measure of the aPSD.

Characteristics of lead aerosols in different work environments

Air samples were collected to examine physical and chemical characteristics of lead aerosols in different work environments in the airborne lead concentration range from 28-783 micrograms/m3. Size distribution of aerosols was measured using a Marple personal cascade impactor, and lead analysis was conducted using graphite atomic absorption spectrometry. Lead aerosol size distribution was found to be different from that of total particles. Such differences are not negligible and must be taken into account when estimating aerosol deposition within the human respiratory tract. Variation of MMAD (mass median aerodynamic diameter) and GSD (geometric standard deviation) of lead aerosols in the coarse mode wit total airborne concentration was found to be small, and the assumption that lead aerosol distribution is constant is reasonable for establishing the relationship between airborne lead concentration in all work areas of the three plants except the charging area of the capacitor plant. Therefore, it is expected that either total airborne lead or respirable airborne lead concentration can be used to correlate blood lead concentration.

Effect of aerosol size on the blood lead distribution of industrial workers

The size distribution measurements of lead aerosol from a brass foundry and primary lead smelter are used to simulate blood lead distributions applying a pharmacokinetic model developed by Bernard. The predicted distribution of blood lead levels determined using the actual size distribution of lead aerosol are compared to the blood lead levels predicted according to the model assumptions adopted in setting the OSHA lead standard. In the furnace area of the smelter and the pouring area of the foundry the predicted mean blood lead level is higher than that found in the standard whereas, in the smelter's sintering and mixing operation the blood lead level is less than that suggested by the standard. The data support the conclusion that size-selective sampling needs to be considered for incorporation into the OSHA lead standard.